• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SRAX Announces Sale Of Its Wholly Owned Subsidiary LD Micro To Freedom Holding For $8.3M

    3/6/23 8:05:48 AM ET
    $FRHC
    $SRAX
    Investment Bankers/Brokers/Service
    Finance
    Advertising
    Consumer Discretionary
    Get the next $FRHC alert in real time by email
    SRAX Announces Sale Of Its Wholly Owned Subsidiary LD Micro To Freedom Holding For $8.3M
    Get the next $FRHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRHC
    $SRAX

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $FRHC
    $SRAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Freedom Bank Kazakhstan Receives Its First Moody's Rating at Ba3 with Stable Outlook

    NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Freedom Holding Corp. (NASDAQ:FRHC), an international fintech group founded by entrepreneur Timur Turlov, announces that Moody's Ratings has assigned its subsidiary, Freedom Bank Kazakhstan, a long-term deposit rating of Ba3 with a stable outlook. This marks Moody's first rating of the bank and an important milestone in its development and international recognition. The rating reflects the bank's solid capitalization, dynamic growth in its customer base and deposit portfolio, and continued development of its retail and digital businesses. Moody's also highlights the important role of Freedom Bank within the ecosystem of Freedom Holding Corp.,

    3/18/26 2:24:46 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Freedom Holding Corp. to Acquire 99.32% Stake in Turkish Bank A.Ş.

    NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Freedom Holding Corp. (NASDAQ:FRHC), an international financial technology group founded by entrepreneur Timur Turlov, has announced an agreement to acquire 99.32% of the shares in Turkish Bank A.Ş. The sellers are Özyol Holding and the National Bank of Kuwait. The transaction is subject to approval by the relevant regulatory authorities in Turkey. The parties had previously announced their intention to conclude the deal, but the key parameters have now been disclosed, including the size of the stake being acquired. The purchase of the bank provides Freedom Holding Corp. with direct access to Turkey's banking market, which serves a population

    3/11/26 10:14:44 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Freedom Holding Corp. Reports Financial Results for the Nine Months and Quarter Ended December 31, 2025

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- Freedom Holding Corp. (NASDAQ:FRHC), a diversified financial services and technology group, today announced financial results for the three and nine months ended December 31, 2025, reflecting growth in assets and shareholders' equity, strong operating cash flow generation, and continued expansion of its customer base across core business segments. The holding company's total assets at the end of the third quarter amounted to $12.38 billion, which is 25% higher than at the end of the previous fiscal year - $9.91 billion. The growth in ass

    2/10/26 3:57:00 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    $FRHC
    $SRAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $FRHC
    $SRAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Lukyanov Sergey bought $2,410,320 worth of shares (20,000 units at $120.52), increasing direct ownership by 15% to 152,425 units (SEC Form 4)

    4 - Freedom Holding Corp. (0000924805) (Issuer)

    2/27/26 4:04:32 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Director Gamble Andrew sold $47,756 worth of shares (400 units at $119.39), decreasing direct ownership by 53% to 357 units (SEC Form 4)

    4 - Freedom Holding Corp. (0000924805) (Issuer)

    2/17/26 4:14:54 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Amendment: Director Gamble Andrew was granted 757 shares (SEC Form 4)

    4/A - Freedom Holding Corp. (0000924805) (Issuer)

    9/16/25 6:12:23 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    $FRHC
    $SRAX
    SEC Filings

    View All

    SEC Form 10-Q filed by Freedom Holding Corp.

    10-Q - Freedom Holding Corp. (0000924805) (Filer)

    2/9/26 4:25:05 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by Freedom Holding Corp.

    10-Q - Freedom Holding Corp. (0000924805) (Filer)

    11/7/25 4:07:21 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Freedom Holding Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Freedom Holding Corp. (0000924805) (Filer)

    10/1/25 9:29:21 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    $FRHC
    $SRAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $FRHC
    $SRAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Dawson James initiated coverage on SRAX with a new price target

    Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00

    4/19/21 9:31:00 AM ET
    $SRAX
    Advertising
    Consumer Discretionary

    B. Riley reiterated coverage on SRAX with a new price target

    B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously

    2/12/21 8:22:29 AM ET
    $SRAX
    Advertising
    Consumer Discretionary

    Ladenburg Thalmann initiated coverage on SRAX with a new price target

    Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00

    2/8/21 7:58:16 AM ET
    $SRAX
    Advertising
    Consumer Discretionary

    Officer Lukyanov Sergey bought $2,410,320 worth of shares (20,000 units at $120.52), increasing direct ownership by 15% to 152,425 units (SEC Form 4)

    4 - Freedom Holding Corp. (0000924805) (Issuer)

    2/27/26 4:04:32 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Officer Lukyanov Sergey bought $982,811 worth of shares (5,725 units at $171.67), increasing direct ownership by 5% to 132,425 units (SEC Form 4)

    4 - Freedom Holding Corp. (0000924805) (Issuer)

    9/2/25 4:06:21 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Officer Lukyanov Sergey bought $1,001,974 worth of shares (6,900 units at $145.21), increasing direct ownership by 6% to 126,700 units (SEC Form 4)

    4 - Freedom Holding Corp. (0000924805) (Issuer)

    7/2/25 4:21:07 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    $FRHC
    $SRAX
    Leadership Updates

    Live Leadership Updates

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    SRAX Announces Appointment of New CFO

    Los Angeles, California--(Newsfile Corp. - March 20, 2023) - SRAX, Inc. (NASDAQ:SRAX), a leading financial technology company, has announced the appointment of Alan Urban as the CFO of SRAX. Mr. Urban has over 30 years of experience in corporate finance and accounting. He has previously served in numerous senior management positions, most notably as Chief Financial Officer for ten years at Research Solutions, a provider of SaaS solutions for life science organizations. Mr. Urban also serves on the Board of Directors of GT Biopharma."We are excited to have Alan step into this very important role at SRAX. We believe his 30 years of expertise will be instrumental in getting our accounting t

    3/20/23 9:00:00 AM ET
    $SRAX
    Advertising
    Consumer Discretionary

    Jon V. Rogers Joins Freedom Capital Markets

    Citigroup Veteran Named Freedom Executive Vice President Appointment Recognizes Leadership and Contributions to Future Growth Freedom Capital Markets (FCM), the investment banking and equity capital markets arm of Prime Executions, Inc., a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ:FRHC) is pleased to announce the appointment of Citigroup veteran Jon V. Rogers as Executive Vice President and a member of FCM's Management and Investment Committees. "Jon will play a pivotal role in all strategic initiatives as we continue to expand Freedom's U.S. footprint and offerings. His experience analyzing equity transactions at Citi will also be very beneficial as we build out our inves

    11/16/22 7:30:00 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    $FRHC
    $SRAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

    SC 13G/A - SRAX, Inc. (0001538217) (Subject)

    2/14/24 2:56:29 PM ET
    $SRAX
    Advertising
    Consumer Discretionary

    SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

    SC 13G/A - SRAX, Inc. (0001538217) (Subject)

    2/13/24 7:42:04 PM ET
    $SRAX
    Advertising
    Consumer Discretionary

    SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

    SC 13G/A - SRAX, Inc. (0001538217) (Subject)

    2/14/23 3:07:08 PM ET
    $SRAX
    Advertising
    Consumer Discretionary

    $FRHC
    $SRAX
    Financials

    Live finance-specific insights

    View All

    Freedom Holding Corp. Reports Financial Results for the Nine Months and Quarter Ended December 31, 2025

    NEW YORK, Feb. 10, 2026 /PRNewswire/ -- Freedom Holding Corp. (NASDAQ:FRHC), a diversified financial services and technology group, today announced financial results for the three and nine months ended December 31, 2025, reflecting growth in assets and shareholders' equity, strong operating cash flow generation, and continued expansion of its customer base across core business segments. The holding company's total assets at the end of the third quarter amounted to $12.38 billion, which is 25% higher than at the end of the previous fiscal year - $9.91 billion. The growth in ass

    2/10/26 3:57:00 AM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Freedom Holding Corp. reports 17% revenue growth in Q1 FY2026 driven by strong insurance and banking segments

    NEW YORK, Aug. 9, 2025 /PRNewswire/ -- Freedom Holding Corp. (NASDAQ:FRHC), a diversified financial services and technology group, today announced its unaudited financial results for the first quarter of fiscal year 2026, ended June 30, 2025. FRHC reported a 17% year-over-year increase in revenue, reaching $533.4 million, highlighting the strength and expansion of its multi-segment business model across emerging and developed markets. "Our Q1 results reflect strong momentum across our core verticals and confirm the resilience of our diversified ecosystem," said Timur Turlov, C

    8/9/25 5:39:00 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance

    Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results

    Company Continues Top Line Growth Trend with 23% Increase in Reported Revenue Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multinational diversified financial services holding company with a presence in 22 countries, today announced the financial results for their fiscal year 2025. Highlights include the following: $2.05 billion in revenue versus $1.67 billion for the fiscal year 2024, a 23% increase Net income of $1.40 earnings per diluted share; $1.43 per basic share $9.9 billion in total assets as of March 31, 2025 Headcount of 8,764 as of March 31, 2025 Fiscal 2025 Financial Highlights: The Company recognized revenue of approximately $2.05 billion in fiscal

    6/13/25 5:22:00 PM ET
    $FRHC
    Investment Bankers/Brokers/Service
    Finance